Workshops

Crack-the-calcium – from diagnosis to management of the calcified lesions

Time:
11.10.2024, 8:30 – 13:30

No spots available; registration is closed.

Chair:
Michał Hawranek, Marta Kałużna-Oleksy, Paweł Kralisz

PART 1

(30 min.)

Coronary and Extracoronary Calcium – pathophysiology, diagnosis & consequences – Fizzah Choudry (15 min.)

Coronary Calcium Management – lifestyle and pharmacotherapy – Piotr Dobrowolski (15 min.)

PART 2

(75 min.)

Imaging of the coronary calcium

– CT – Agnieszka Witkowska (12 min.)

– Angiography – Michał Wróbel (12 min.)

– IVUS – Maciej Lesiak (12 min.)

– OCT – Łukasz Pyka (12 min.)

Hands on imaging simulators (27 min.)

Coffee break (15 min.)

PART 3

(60 min. duration
together with hands on)

Crack the calcium: Tools – tips&tricks

– Baloons – Anna Draus (10 min.)

– Atherectomy – Paweł Kralisz (10 min.)

– Laser – Tomasz Pawłowski (10 min.)

Hands on calcium debulking simulators (30 min.)

PART 4

(100 min. duration
together with hands on
)

INTRAVASCULAR LITHOTRIPSY SCHOOL

(session granted by Shockwave)

Chair: Marta Kałużna-Oleksy, Michał Hawranek
  1. Introduction to Intravascular Lithotripsy (IVL) – Michał Hawranek (10 min.)
    • What is IVL? Technology and basic principles
    • Mechanism of Action: How IVL works to modify calcified plaques
  1. Clinical Outcomes and Evidence Base for IVL – Marta Kałużna-Oleksy (10 min.)
    • Clinical Trials and Studies: Review of major studies and outcomes data
    • Safety and Efficacy: Complications, success rates, and long-term outcomes
    • Comparative Effectiveness: IVL vs. other techniques like atherectomy and rotational ablation
  1. IVL in practice – tips & triks (case – based) – Marta Kałużna-Oleksy & Michał Hawranek (30 min.)
    • How to deal with Shockwave balloon
    • In-stent restenosis
    • Bifurcation
    • LM
    • Safety points
    • Own-case experience – discussion with participants

Hands on calcium debulking simulators (50 min.)

PART 5

(20 min.)

Summary

Procedure strategy – when to use which method and how to interpret the images – Stanisław Bartuś (20 min.)

From baseline to residual risk – imaging, lipids and inflammation – how to estimate CV risk in an integrated way

Time:
11.10.2024, 8:30 – 13:30
A workshop aims to provide a comprehensive overview of atherosclerosis, including its definition, causes, and risk factors. Explanation the role of cholesterol, inflammation, and other contributing factors in the development of atherosclerosis and to find the treatment strategy, especially in younger population with long life-expectation.

Chair:
Bartosz Hudzik, Erin D. Michos, Izabella Uchmanowicz

PART 1

(60 min.)

Workshop under the patronage of Novo Nordisk

Jakub Morze

Inflammation and its role in the development of atherosclerotic diseases – how to investigate and treat (15 min.)

– Clinical cases – characteristics and clinical problems (10 min.)
– Case interpretation by the participants (20 min.)
– Case solutions (10 min.)
– Key learnings (5 min.)

Coffee break (15 min.)

PART 2

(120 min.)

Chair: Cezary Kępka, Mariusz Kruk

The role of CT in coronary artery disease diagnosis and risk assessment (15 min.)

– Clinical cases – characteristics and clinical problems
– Hands on CT simulators
– Case solutions
– Key learnings 

Coffee break (15 min.)

PART 3

(75 min.)

Sanofi

Addressing hypercholesterolemia – state of the art in the diagnosis, risk assessment and treatment of lipid disorders – Maciej Banach (15 min.)

– Clinical cases – characteristics and clinical problems (10 min.)  – Tadeusz Osadnik / Marta Kałużna-Oleksy
– Case interpretation by participants (20 min.)
– Case solutions (10 min.)
– Key learnings (5 min.)

ESC news – hypercholesterolemia –  Marta Kałużna-Oleksy (15 min.)

PART 4

(15 min.)

Session wrap-up – Erin D. Michos

Optimizing Outcomes: The role of physiology and imaging in enhancing percutaneous coronary intervention safety and efficacy

Time:
12.10.2024, 9:00 – 11:00

No spots available; registration is closed.

The session includes case studies, practical examples, and interactive elements to engage the audience and facilitate a deeper understanding of the topic. Additionally, consider discussing any emerging trends or research in the field of intracoronary imaging and physiology.

Chair: Mila Kovacevic

Co-chair: Marta Kałużna-Oleksy, Łukasz Pyka, Nicola Ryan

Programme:

  1. Physiology and imaging in coronary artery diesease – indication and interpretation – Jacek Legutko
  2. Clinical cases x 3 – characteristics and clinical problems – Nicola Ryan / Michał Wróbel / Łukasz Pyka
  3. Case interpretation by the participants
  4. Case solutions: Nicola Ryan / Michał Wróbel / Łukasz Pyka
  5. Key learnings – Marta Kałużna-Oleksy, Jacek Legutko

Striking the Balance – Mastering Antithrombotic Therapy: A guide to balancing bleeding and ischemic risks

Time:
12.10.2024, 12:50 – 15:15

Chair: Jolanta Siller-Matula

Co-chair: Bartosz Hudzik, Loreta Kallirroi Kalantzi

No spots available; registration is closed.

Programme:

  1. An overview of antithrombotic therapy – mechanisms of action of antiplatelet therapy – Jolanta Siller-Matula (10 min.)
  2. An overview of antithrombotic therapy – mechanism of action of anticoagulant therapy – Loreta Kallirroi Kalantzi (10 min.)
  3. Risk Assessment Tools in Antithrombotic Therapy – Bartosz Hudzik (15 min.)
  4. Complex PCI – ischemic risk matters – Maciej Marciniak (15 min.) 
  5. Personalized approach – How to tailor antithrombotic therapy based on individual patient characteristics, including genetic factors, comorbidities, and patient preferences – case-based discussion:
    – DAPT in high-bleeding risk patient (7+10 min.)
    – DAPT in low-bleeding risk patient (7+10 min.)
    – TAT in high-bleeding risk patient (7+10 min.)
    – TAT in low-bleeding risk patient (7+10 min.)
  6. Does sex matter in antithrombotic management? – Jolanta Siller-Matula  (10 min.)
  7. Session wrap up – Bartosz Hudzik (3 min.)

Imaging the Heart: Mastering the art of valvular disease diagnosis

Time:
12.10.2024, 15:25 – 17:40

No spots available; registration is closed.

Chair: Agnieszka Kapłon-Cieślicka, Adam Rdzanek, Piotr Scisło

Warsztat w j. polskim / Workshop in Polish


Diagnostics and treatment of valve diseases with special emphasis on the mitral and tricuspid valves – case-based learning: Agnieszka Kapłon-Cieślicka, Piotr Scisło

Percutaneous interventions on the tricuspid valve – new technologies, new challenges – TricValve and edge-to-edge procedures – Adam Rdzanek

Workshop Objectives:

  1. Understand the Fundamentals of Valvular Heart Disease: Gain a comprehensive understanding of the pathophysiology, clinical manifestations, and progression of common and rare valvular heart diseases.
  2. Master Imaging Techniques: Develop proficiency in utilizing echocardiography (both transthoracic and transesophageal) for the accurate diagnosis of valvular disease.
  3. Apply Guidelines in Clinical Practice: Familiarize with the latest guidelines and recommendations for the diagnosis and management of valvular heart diseases, integrating them into clinical decision-making.
  4. Recognize Indications for Intervention: Identify the clinical and imaging criteria that signal the need for surgical or percutaneous intervention in patients with valvular heart disease.
  5. Manage Complex Cases: Enhance skills in managing complex valvular disease cases through interactive case studies, focusing on integrating clinical evaluation with imaging findings to guide treatment strategies.
  6. Innovations and Future Directions: Explore the latest advances and emerging technologies in cardiac imaging for valvular disease, including 3D imaging and artificial intelligence applications.
  7. Collaborative Decision Making: Improve the ability to work effectively within a multidisciplinary team, emphasizing the role of imaging specialists in collaboration with cardiologists, cardiac surgeons, and other healthcare professionals in the management of valvular disease.
  8. Patient-Centered Approach: Enhance communication skills to effectively convey imaging findings and treatment options to patients, ensuring informed decision-making and patient-centered care.